The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Addition of stereotactic body radiotherapy (SBRT) to systemic chemotherapy in locally advanced cholangiocarcinoma (CC) (ABC-07): Results from a randomized phase II trial.
 
Maria A. Hawkins
No Relationships to Disclose
 
Juan W. Valle
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Autem Medical; Baxter; Boehringer Ingelheim; Cantargia AB; Debiopharm Group; Delcath Systems; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Medivir; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Sirtex Medical; Taiho Oncology; Wren Laboratories; Zymeworks
Speakers' Bureau - Delcath Systems; Imaging Equipment Limited; Incyte; Ipsen; Mylan; Novartis; Nucana; SERVIER
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Lilly; Nucana; Roche
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Celgene; Erytech Pharma; Incyte; Merck KGaA; Roche/Genentech; SERVIER; Sirtex Medical; Zymeworks
Consulting or Advisory Role - Bayer; Celgene; Incyte; National Institute for Health and Clinical Excellence; Oaktree life sciences; OncoSil; Pierre Fabre
Speakers' Bureau - Amgen; Bayer; Exact Therapeutics; Incyte; Merck KGaA; Pfizer; Pierre Fabre; Seagen; SERVIER; Takeda; Zymeworks
Research Funding - Merck Serono (Inst); MSD (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Mark Harrison
No Relationships to Disclose
 
Helen Morement
Consulting or Advisory Role - Incyte, Servier
 
Prakash Manoharan
Consulting or Advisory Role - Novartis
 
Ganesh Radhakrishna
No Relationships to Disclose
 
David Eaton
Travel, Accommodations, Expenses - Vision RT
 
Douglas Brand
Employment - Merck Sharp & Dohme (I)
Stock and Other Ownership Interests - Merck Sharp & Dohme (I)
 
Temi Adedoyin
No Relationships to Disclose
 
Ka Man Mak
Stock and Other Ownership Interests - Pfizer
 
Natasha Hava
No Relationships to Disclose
 
Shumona Shelly
No Relationships to Disclose
 
Memuna Rashid
No Relationships to Disclose
 
Andre Lopes
No Relationships to Disclose
 
John A Bridgewater
Honoraria - Incyte; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Merck Serono; Roche; SERVIER; Taiho Oncology
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene
Research Funding - Amgen; Incyte (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER